Skip to main content
Erschienen in: Drugs & Aging 8/2009

01.08.2009 | Original Research Article

Impact of Residential Medication Management Reviews on Drug Burden Index in Aged-Care Homes

A Retrospective Analysis

verfasst von: Mr Prasad S. Nishtala, Sarah N. Hilmer, Andrew J. McLachlan, Paul J. Hannan, Timothy F. Chen

Erschienen in: Drugs & Aging | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

The Drug Burden Index (DBI) is an evidence-based tool that associates medication exposure with functional outcomes in older people. Accredited clinical pharmacists performing medication reviews could consider including the DBI in their medication reviews to optimize prescribing in older people.

Objective

To examine the impact of residential medication management reviews (RMMRs) performed by accredited clinical pharmacists on DBI in older people living in aged-care homes.

Methods

A retrospective analysis was performed of a random sample of 500 de-identified RMMR reports from residents aged (mean±SD) 84±9.0 years who had medication reviews conducted by ten accredited clinical pharmacists from 1 January 2008 through 30 June 2008. The data on medication use were collected over 8 months across 62 aged-care homes. DBI scores were calculated at baseline, after the recommendations had been made by the pharmacist and after uptake of pharmacist recommendations by the general practitioner (GP).

Results

A statistically significant decrease (p<0.001) in median DBI score was observed as a result of uptake of pharmacist recommendations by the GP. GPs were more likely to take up recommendations made by pharmacists that resulted in a decrease in DBI score than recommendations that resulted in an increase in DBI score (60.7% vs 34.6%, respectively). The mean decrease in DBI as a result of pharmacist recommendations was 0.12 (95% CI 0.09, 0.14) representing a 20% decrease in mean baseline DBI for residents. When GPs implemented pharmacists’ recommendations, DBI decreased by a mean of 12% from baseline (mean decrease 0.07; 95% CI 0.05, 0.08). Most of the recommendations proposed by the pharmacists involved withdrawing benzodiazepines or reducing antipsychotic drug dosage.

Conclusions

This is the first study in which DBI has been used as a tool to evaluate the impact of RMMRs conducted by accredited clinical pharmacists. The study demonstrates that pharmacist-conducted medication reviews can reduce prescribing of sedative and anticholinergic drugs in older people, resulting in a significant decrease in the DBI score.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56(2): 163–84PubMedCrossRef McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56(2): 163–84PubMedCrossRef
2.
Zurück zum Zitat Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007; 21(3): 217–30PubMedCrossRef Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007; 21(3): 217–30PubMedCrossRef
3.
Zurück zum Zitat Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009; 85(1): 86–8PubMedCrossRef Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009; 85(1): 86–8PubMedCrossRef
4.
Zurück zum Zitat Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341(27): 2061–7PubMedCrossRef Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341(27): 2061–7PubMedCrossRef
5.
Zurück zum Zitat Wenger NK. Enrollment and maintenance of elderly patients in cardiovascular clinical trials. Am J Geriatr Cardiol 2006; 15(6): 352–6PubMedCrossRef Wenger NK. Enrollment and maintenance of elderly patients in cardiovascular clinical trials. Am J Geriatr Cardiol 2006; 15(6): 352–6PubMedCrossRef
6.
Zurück zum Zitat Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716–24PubMedCrossRef Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716–24PubMedCrossRef
7.
Zurück zum Zitat Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging 2008; 25(9): 777–93PubMedCrossRef Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging 2008; 25(9): 777–93PubMedCrossRef
8.
Zurück zum Zitat Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294(6): 716–24PubMedCrossRef Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294(6): 716–24PubMedCrossRef
9.
Zurück zum Zitat Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332(9): 556–61PubMedCrossRef Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332(9): 556–61PubMedCrossRef
10.
Zurück zum Zitat Terry DF, Sebastiani P, Andersen SL, et al. Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med 2008; 168(3): 277–83PubMedCrossRef Terry DF, Sebastiani P, Andersen SL, et al. Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med 2008; 168(3): 277–83PubMedCrossRef
11.
Zurück zum Zitat Gray SL, LaCroix AZ, Hanlon JT, et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006; 54(2): 224–30PubMedCrossRef Gray SL, LaCroix AZ, Hanlon JT, et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006; 54(2): 224–30PubMedCrossRef
12.
Zurück zum Zitat Mulsant BH, Pollock BG, Kirshner M, et al. Serum antic-holinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 2003; 60(2): 198–203PubMedCrossRef Mulsant BH, Pollock BG, Kirshner M, et al. Serum antic-holinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 2003; 60(2): 198–203PubMedCrossRef
13.
Zurück zum Zitat Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167(8): 781–7PubMedCrossRef Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167(8): 781–7PubMedCrossRef
14.
Zurück zum Zitat Iyer S, Naganathan V, McLachlan AJ, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008; 25(12): 1021–31PubMedCrossRef Iyer S, Naganathan V, McLachlan AJ, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008; 25(12): 1021–31PubMedCrossRef
15.
Zurück zum Zitat Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2007; 81(2): 235–41PubMedCrossRef Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2007; 81(2): 235–41PubMedCrossRef
16.
Zurück zum Zitat Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2008; 83(3): 422–9PubMedCrossRef Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2008; 83(3): 422–9PubMedCrossRef
17.
Zurück zum Zitat Gnjidic D, Cumming RG, Le Couteur DG, et al. Drug burden index and physical function in older Australian men. Br J Clin Pharmacol 2009 Jul; 68(1): 97–105PubMedCrossRef Gnjidic D, Cumming RG, Le Couteur DG, et al. Drug burden index and physical function in older Australian men. Br J Clin Pharmacol 2009 Jul; 68(1): 97–105PubMedCrossRef
18.
Zurück zum Zitat Rosano C, Simonsick EM, Harris TB, et al. Association between physical and cognitive function in healthy elderly: the Health, Aging and Body Composition study. Neuro-epidemiology 2005; 24(1–2): 8–14 Rosano C, Simonsick EM, Harris TB, et al. Association between physical and cognitive function in healthy elderly: the Health, Aging and Body Composition study. Neuro-epidemiology 2005; 24(1–2): 8–14
19.
Zurück zum Zitat Campbell AJ, Robertson MC, Gardner MM, et al. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999; 47(7): 850–3PubMed Campbell AJ, Robertson MC, Gardner MM, et al. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999; 47(7): 850–3PubMed
20.
Zurück zum Zitat van der Velde N, Stricker BH, Pols HA, et al. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging 2007; 24(8): 691–9PubMedCrossRef van der Velde N, Stricker BH, Pols HA, et al. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging 2007; 24(8): 691–9PubMedCrossRef
21.
Zurück zum Zitat Ballard C, Hanney ML, Theodoulou M, et al. The Dementia Antipsychotic Withdrawal Trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009; 8(2): 151–7PubMedCrossRef Ballard C, Hanney ML, Theodoulou M, et al. The Dementia Antipsychotic Withdrawal Trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009; 8(2): 151–7PubMedCrossRef
22.
Zurück zum Zitat Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001; 51(3): 257–65PubMedCrossRef Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001; 51(3): 257–65PubMedCrossRef
24.
Zurück zum Zitat Nissen D. editor. Mosby’s drug consult. St Louis (MO): Mosby Inc., 2004 Nissen D. editor. Mosby’s drug consult. St Louis (MO): Mosby Inc., 2004
25.
Zurück zum Zitat Duplay D. editor. Physicians’ Desk Reference. 58th ed. Montvale (NJ): Thomson PDR, 2004 Duplay D. editor. Physicians’ Desk Reference. 58th ed. Montvale (NJ): Thomson PDR, 2004
26.
Zurück zum Zitat Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp Ther 2001; 298(3): 865–72PubMed Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp Ther 2001; 298(3): 865–72PubMed
27.
Zurück zum Zitat Nishtala PS, McLachlan AJ, Bell JS, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16(8): 621–32PubMedCrossRef Nishtala PS, McLachlan AJ, Bell JS, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16(8): 621–32PubMedCrossRef
28.
Zurück zum Zitat Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17(11): 825–37PubMedCrossRef Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17(11): 825–37PubMedCrossRef
29.
Zurück zum Zitat Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316(7): 363–9PubMedCrossRef Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316(7): 363–9PubMedCrossRef
30.
Zurück zum Zitat Mort JR, Aparasu RR. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs 2002; 16(2): 99–109PubMedCrossRef Mort JR, Aparasu RR. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs 2002; 16(2): 99–109PubMedCrossRef
31.
Zurück zum Zitat Rochon PA, Normand SL, Gomes T, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008; 168(10): 1090–6PubMedCrossRef Rochon PA, Normand SL, Gomes T, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008; 168(10): 1090–6PubMedCrossRef
32.
Zurück zum Zitat Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006; 332(7539): 455–9PubMedCrossRef Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006; 332(7539): 455–9PubMedCrossRef
33.
Zurück zum Zitat Bottiggi KA, Salazar JC, Yu L, et al. Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry 2006; 14(11): 980–4PubMedCrossRef Bottiggi KA, Salazar JC, Yu L, et al. Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry 2006; 14(11): 980–4PubMedCrossRef
34.
Zurück zum Zitat Hutt E, Pepper GA, Vojir C, et al. Assessing the appropriateness of pain medication prescribing practices in nursing homes. J Am Geriatr Soc 2006; 54(2): 231–9PubMedCrossRef Hutt E, Pepper GA, Vojir C, et al. Assessing the appropriateness of pain medication prescribing practices in nursing homes. J Am Geriatr Soc 2006; 54(2): 231–9PubMedCrossRef
35.
Zurück zum Zitat Sorensen L, Stokes JA, Purdie DM, et al. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58(6): 648–64PubMedCrossRef Sorensen L, Stokes JA, Purdie DM, et al. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58(6): 648–64PubMedCrossRef
36.
Zurück zum Zitat Patel HR, Pruchnicki MC, Hall LE. Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacother 2005; 39(1): 22–7PubMed Patel HR, Pruchnicki MC, Hall LE. Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacother 2005; 39(1): 22–7PubMed
37.
Zurück zum Zitat Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30(3): 205–11PubMedCrossRef Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30(3): 205–11PubMedCrossRef
38.
Zurück zum Zitat O’Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann Pharmacother 2005; 39(9): 1423–7PubMedCrossRef O’Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann Pharmacother 2005; 39(9): 1423–7PubMedCrossRef
39.
Zurück zum Zitat Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003; 169(1): 17–22PubMed Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003; 169(1): 17–22PubMed
40.
Zurück zum Zitat Schmidt IK, Claesson CB, Westerholm B, et al. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998; 32(1): 27–32PubMedCrossRef Schmidt IK, Claesson CB, Westerholm B, et al. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998; 32(1): 27–32PubMedCrossRef
41.
Zurück zum Zitat Department of Health and Ageing, Commonwealth of Australia. A literature review and description of the regulatory framework. 2005 Nov [online]. Available from URL: http://www.health.gov.au [Accessed 2008 Nov 28] Department of Health and Ageing, Commonwealth of Australia. A literature review and description of the regulatory framework. 2005 Nov [online]. Available from URL: http://​www.​health.​gov.​au [Accessed 2008 Nov 28]
Metadaten
Titel
Impact of Residential Medication Management Reviews on Drug Burden Index in Aged-Care Homes
A Retrospective Analysis
verfasst von
Mr Prasad S. Nishtala
Sarah N. Hilmer
Andrew J. McLachlan
Paul J. Hannan
Timothy F. Chen
Publikationsdatum
01.08.2009
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 8/2009
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.2165/11316440-000000000-00000

Weitere Artikel der Ausgabe 8/2009

Drugs & Aging 8/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.